On November 25, 2012, the site team for our new Israeli study of MDMA-assisted psychotherapy for PTSD began collecting inquiries for participation in the study, beginning the screening process. In-person …
On October 25, 2012, the zoning office for the City of Boulder, Colorado, issued the business license for the site for our upcoming study of MDMA-assisted psychotherapy for PTSD. This license was required …
On October 16, 2012, the zoning office for the city of Boulder, Colorado, approved the business license for the site for our upcoming study of MDMA-assisted psychotherapy in Boulder. The local Drug Enforcement …
On September 21, 2012, the paper describing the results of our completed Swiss Phase 2 pilot study of MDMA-assisted psychotherapy in 12 subjects with chronic, treatment-resistant PTSD was accepted for …
On August 30, 2012, the official study kickoff meeting took place for our new Israeli study of MDMA-assisted psychotherapy for PTSD. Israeli CRA Mimi Peleg traveled from Israel to meet with MAPS Lead Clinical …
On July 31, 2012, an inspector from the U.S. Drug Enforcement Administration conducted the scheduled inspection of the site for our planned study of MDMA-assisted psychotherapy for PTSD in Boulder, Colorado. …
On July 13, 2012, the Ethics Committee reviewed our responses to its initial rejection of the protocol for our proposed Australian study of MDMA-assisted psychotherapy for PTSD, to be co-sponsored by the …
On June 7, 2012, Mimi Peleg, the new Clinical Research Associate for MAPS’ upcoming Israeli study of MDMA-assisted psychotherapy for PTSD completed a site visit report to help the study investigators …
MAPS is working with an Australian non-profit organization, Psychedelic Research in Science and Medicine (PRISM), to obtain approval for a new Australian study of MDMA-assisted psychotherapy for PTSD. …
MAPS is working with an Australian non-profit organization, Psychedelic Research in Science and Medicine (PRISM), to obtain approval for a new Australian study of MDMA-assisted psychotherapy for PTSD. …
On May 15, 2012, the U.S. Drug Enforcement Administration approved the protocol for our upcoming study of MDMA-assisted psychotherapy for PTSD, to take place in Boulder, Colorado, with Principal Investigator …
On May 4, 2012, the U.S. Food and Drug Administration notified the MAPS clinical team that our new “intern study” of MDMA-assisted psychotherapy for subjects with PTSD had been cleared for …